LeAnne Skordos

Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease

Samantha Budd Haeberlein, Paul Aisen, Frederik Barkhof et al. · The Journal of Prevention of Alzheimer s Disease · 2022 · 1.3K citations · Full text

Medicine, Neurology, Pharmacology +17

Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates

Jason M. Stinnett, Robert C. Pendleton, LeAnne Skordos et al. · American Journal of Hematology · 2005 · 101 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +16

Clinical Development of Aducanumab, an Anti-Aβ Human Monoclonal Antibody Being Investigated for the Treatment of Early Alzheimer's Disease.

Samantha Budd Haeberlein, John O’Gorman, Ping-Chun Chiao et al. · PubMed · 2017 · 86 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Emerge and Engage topline results: Phase 3 studies of aducanumab in early Alzheimer’s disease

Samantha Budd Haeberlein, Christian von Hehn, Ying Tian et al. · Alzheimer s & Dementia · 2020 · 78 citations · Full text

Medicine, Neurology, Pharmacology +17

Baseline Characteristics From ENGAGE and EMERGE: Two Phase 3 Studies to Evaluate Aducanumab in Patients With Early Alzheimer’s Disease (P4.1-001)

Christian von Hehn, Philipp von Rosenstiel, Ying Tian et al. · Neurology · 2019 · 15 citations

Medicine, Neurology, Neuroscience +13